These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 10226111

  • 1. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
    Charco R, Cantarell C, Vargas V, Capdevila L, Lázaro JL, Hidalgo E, Murio E, Margarit C.
    Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111
    [Abstract] [Full Text] [Related]

  • 2. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus.
    Trotter JF, Wachs ME, Trouillot TE, Bak T, Kugelmas M, Kam I, Everson G.
    Liver Transpl; 2001 May; 7(5):401-8. PubMed ID: 11349259
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 4. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B, Kubanek M, Malek I, Vymetalova Y, Hoskova L, Podzimkova M, Kautzner J.
    J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
    [Abstract] [Full Text] [Related]

  • 8. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation.
    Guckelberger O, Bechstein WO, Neuhaus R, Luesebrink R, Lemmens HP, Kratschmer B, Jonas S, Neuhaus PL.
    Clin Transplant; 1997 Feb; 11(1):60-5. PubMed ID: 9067697
    [Abstract] [Full Text] [Related]

  • 10. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients.
    Manzarbeitia C, Reich DJ, Rothstein KD, Braitman LE, Levin S, Munoz SJ.
    Liver Transpl; 2001 Feb; 7(2):93-9. PubMed ID: 11172391
    [Abstract] [Full Text] [Related]

  • 11. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
    Fernández-Miranda C, de la Calle A, Morales JM, Guijarro C, Aranda JL, Gómez-Sanz R, Gómez-Izquierdo T, Larumbe S, Moreno E, Rodicio JL, del Palacio A.
    Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
    [Abstract] [Full Text] [Related]

  • 12. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus.
    Imamura R, Ichimaru N, Moriyama T, Shi Y, Namba Y, Nonomura N, Matsumiya K, Toki K, Takahara S, Okuyama A.
    Clin Transplant; 2005 Oct; 19(5):616-21. PubMed ID: 16146552
    [Abstract] [Full Text] [Related]

  • 13. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC, Hwang EA, Han SY, Park SB, Kim HT, Cho WH.
    Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
    [Abstract] [Full Text] [Related]

  • 14. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
    Ott R, Bussenius-Kammerer M, Reck T, Koch CA, Kissler H, Hohenberger W, Müller V.
    Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis.
    Chueh SC, Kahan BD.
    Transplantation; 2003 Jul 27; 76(2):375-82. PubMed ID: 12883196
    [Abstract] [Full Text] [Related]

  • 17. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 27; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens.
    Law YM, Yim R, Agatisa P, Boyle GJ, Miller SA, Lawrence K, Webber SA.
    J Heart Lung Transplant; 2006 Mar 27; 25(3):276-82. PubMed ID: 16507419
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E, Devogelaer JP, Lalaoui A, Depresseux G, De Naeyer P, Squifflet JP, Pirson Y, van Ypersele de Strihou C.
    Transpl Int; 2002 Mar 27; 15(2-3):73-80. PubMed ID: 11935163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.